|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of Homo sapiens gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis) DNA.|
|DRM, PIG2, DAND2, IHG-2, GREMLIN, CKTSF1B1, MGC126660|
|Identical with the Gene Bank Ref. ID sequence except for the point mutation 207 C/G not causing the amino acid variation.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Human GREM1 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||HG10632-G-F|
|Human GREM1 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||HG10632-G-H|
|Human GREM1 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||HG10632-G-M|
|Human GREM1 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||HG10632-G-N|
|Human GREM1 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||HG10632-G-Y|
|Product name||Product name|
GREM1 belongs to the DAN family. It contains 1 CTCK (C-terminal cystine knot-like) domain. GREM1 is a cysteine knot-secreted protein and acts as an inhibitor in the TGF beta signaling pathway. It inhibits BMP-2, -4, and -7. Inhibition by grem 1 of BMPs in mice allow the expression of fibroblast growth factors (FGFs) 4 and 8 and Sonic hedgehog (SHH) which are necessary for proper limb development. It interacts with SLIT1 and SLIT2 in a glycosylation-dependent manner. As a cytokine, GREM1 may play an important role during carcinogenesis and metanephric kidney organogenesis, as a BMP antagonist required for early limb outgrowth and patterning in maintaining the FGF4-SHH feedback loop. It down-regulates the BMP4 signaling in a dose-dependent manner. It also acts as inhibitor of monocyte chemotaxis. GREM1 is highly expressed in small intestine, fetal brain and colon.